Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of the Hip Innovation Technology Reverse Hip Replacement System in Primary Total Hip Arthroplasty: A Pivotal Study

NCT05357378 is registered in ClinicalTrials.gov with Hip Innovation Technology as lead sponsor.

NCT NCT05357378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05357378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of the Hip Innovation Technology Reverse Hip Replacement System in Primary Total Hip Arthroplasty: A Pivotal Study
Lead sponsor
Hip Innovation Technology
Phase
Not applicable
Overall status
Recruiting
Start date
July 15, 2022
Completion date
September 16, 2038
Enrollment
288 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis of hip, degenerative joint disease, osteoarthritis, hip, traumatic arthropathy-hip